More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Speaks at Fourth International Congress of Neuroscience in São Paulo, Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Speaks at Fourth International Congress of Neuroscience in São Paulo, Brazil

by adminAdrianRamirez | Oct 15, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, Oct. 15, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that an executive from its subsidiary HempMeds® Brasil spoke on the benefits of cannabidiol (CBD) hemp...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil

by adminAdrianRamirez | Oct 2, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, Oct. 2, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil has released a new full-spectrum 5,000 mg cannabidiol (CBD) hemp oil...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Event on the Benefits of CBD with Former Resident Doctors of Neurology in Belo Horizonte, Brazil

by adminAdrianRamirez | Aug 23, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, Aug. 23, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil will host the Third Meeting of Former Residents of Neurology at John Paul II...
Medical Marijuana, Inc. Featured on San Diego Community Radio Show Discussing International Expansion and Shifting CBD Laws

Medical Marijuana, Inc. Featured on San Diego Community Radio Show Discussing International Expansion and Shifting CBD Laws

by adminAdrianRamirez | Jul 18, 2018 | HempMeds, HempMeds Brasil, Press Releases

Two Fathers from Texas and Brazil Discuss How the Company’s CBD Oil Helped Their Daughters SAN DIEGO, Calif., July 18, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has...
The Guardian, Benzinga, Oracle Dispatch, and More Highlight Achievements from Our Family of Companies

The Guardian, Benzinga, Oracle Dispatch, and More Highlight Achievements from Our Family of Companies

by adminAdrianRamirez | Jun 25, 2018 | HempMeds, HempMeds Brasil, Kannaway, Media Coverage

Medical Marijuana, Inc. and our portfolio of companies in the cannabis industry were once again in the news this week as CBD products continue to grow in popularity. A Company of Firsts®, Medical Marijuana, Inc. is once again driving the CBD oil industry by...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Norberto Fischer as New Company Spokesperson

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Norberto Fischer as New Company Spokesperson

by adminAdrianRamirez | Jun 20, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, June 20, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that Norberto Fischer has joined as spokesperson for the company. “We’re very...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Subscribe for Company Updates

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.